Gary Herschman, Member of the Firm, co-presents “Healthcare M&A on Steroids: 2021 and Beyond,” for the Denver Medical Study Group.
Healthcare merger and acquisition activity in 2021 has been more robust than anticipated, with over 3,000 total transactions expected by year-end. That represents an increase of more than 25% as compared to 2020. The heightened level of investor interest and mergers in the healthcare sector will likely continue through 2022 and beyond.
Key takeaways include:
- Overview of the super-robust 2021 healthcare M&A activity, and predictions for 2022
- Key factors driving the growth of investment and M&A activity in the healthcare industry
- The pros and cons of partnerships with private equity investors
- How to prepare your company for a strategic transaction, and overview of the transaction process
Please note there is a $15 charge for this event. To register, please visit GoToWebinar.com.